• Sodium chloride: Buffer Preparation and QC

  2026-09-10

  Sodium chloride is an inorganic salt used to set ionic strength and support osmotic balance in aqueous buffers, biochemical assays, and cell culture media workflows. This guide covers preparation, storage, and QC boundaries while clarifying that the reagent should be dissolved in water rather than DMSO or ethanol and should not be treated as a sterility-qualified or pH-buffering material.

• Reparixin: A CXCR1/2 Lens on IL-8 Biology

  2026-09-10

  Reparixin is a CXCR1/2 inhibitor that enables receptor-level analysis of IL-8 signaling across neutrophil, tissue-injury, and tumor models. This article translates recent MRSA extracellular-vesicle findings into practical assay decisions while distinguishing established evidence from proposed applications.

• From Cassava Stress Genes to Translational PCR Strategy

  2026-09-09

  A mechanistic and strategic guide to using endpoint PCR to validate stress-response genes, support TA cloning, and build more reproducible translational workflows around cassava A20/AN1 research.

• Cyclophosphamide: From Bioactivation to Assay Design

  2026-09-09

  Cyclophosphamide is an alkylating chemotherapeutic agent whose hepatic bioactivation makes experimental interpretation highly dependent on model context. This guide connects DNA damage biology, topotecan-based mechanistic insight, immune endpoints, and reproducible assay design.

• Ibotenic Acid Toxicity in Mice: Dose and Time

  2026-09-08

  A 2026 study provides a systematic murine assessment of ibotenic acid toxicity across behavioral, biochemical, histopathological, and immunohistochemical endpoints. Its findings distinguish reversible early responses at a lower exposure from severe toxicity, mortality, and neuronal injury markers at a higher exposure, helping define the compound’s acute toxicological window.

• H-89 and the PKA Gate in Wnt Bone Biology

  2026-09-08

  Wnt-driven osteogenesis is increasingly understood as a signaling–metabolism problem, not only a transcriptional one. This thought-leadership guide explains how H-89 can help translational researchers test the Ca2+-PKA-GFAT1 axis while preserving the controls needed to distinguish PKA-dependent biology from chemical-probe artifacts.

• Remdesivir (GS-5734): Mechanism and Evidence

  2026-09-07

  Remdesivir, also called GS-5734, is a phosphoramidate prodrug that delivers a nucleotide analogue to viral RNA-dependent RNA polymerases. Evidence spans coronavirus antiviral research, Ebola virus treatment research, and structural studies of viral polymerase complexes, but cell-based potency and animal protection do not establish efficacy against every RNA virus.

• Cholesterol for mRNA-LNP Research

  2026-09-07

  Cholesterol connects membrane biophysics with practical lipid nanoparticle workflows for localized mRNA delivery. This guide translates an intravesical p21 mRNA-LNP study into reproducible formulation, assay, and troubleshooting decisions while distinguishing validated findings from optimization recommendations.

• GSK-923295: A Strategic Probe of Mitotic Fidelity

  2026-09-04

  GSK-923295 offers translational researchers a chemically defined way to interrogate CENP-E motor function, chromosome alignment, and mitotic fidelity. By integrating CENP-E inhibition with emerging evidence on CTCF-dependent centromere architecture, this article outlines a practical framework for mechanistic studies, cancer research, and preclinical decision-making.

• Cholesterol for mRNA-LNP Membrane Research

  2026-09-04

  Learn how Cholesterol B1702 can improve the interpretability of lipid nanoparticle, membrane fluidity, and lipid metabolism experiments. This workflow translates localized p21 mRNA-LNP findings into practical formulation, assay-design, and troubleshooting decisions without overstating what the reference study directly demonstrated.

• Oligo (dT) 25 Beads: Practical mRNA Workflow

  2026-09-03

  Oligo (dT) 25 Beads support selective capture of polyadenylated eukaryotic mRNA from total RNA or animal and plant cell or tissue samples. They are appropriate for polyA-selected mRNA workflows, but not as a general substitute for total RNA purification or for samples dominated by non-polyadenylated or prokaryotic RNA.

• Liproxstatin-1 and the Next Ferroptosis Frontier

  2026-09-03

  Ferroptosis research is moving from redox initiation toward the plasma-membrane events that determine cell rupture. This thought-leadership guide positions Liproxstatin-1 as a mechanistic ferroptosis inhibitor for separating lipid-peroxide accumulation from membrane execution, while outlining translational strategies for renal injury and immuno-oncology models.

• Kupffer Cell Plasticity in Liver Metastasis

  2026-09-02

  This study shows that liver metastasis-associated macrophages are maintained not only by recruited monocytes but also by local macrophage proliferation and infiltration of reprogrammed Kupffer cells. Its lineage-tracing and multiomic design clarifies why blocking monocyte-derived macrophages alone may produce limited remodeling of the immunosuppressive metastatic niche.

• MAPK10–KRT16 Signaling Suppresses NSCLC Metastasis

  2026-09-02

  The reference study identifies a phosphorylation-dependent MAPK10/KRT16/RNF213 pathway that limits non-small cell lung cancer metastasis by promoting KRT16 ubiquitination and proteasomal degradation. Its integrated cellular, animal, and clinical evidence supports a mechanistic model for biomarker development while indicating that pathway-specific validation remains necessary before therapeutic translation.

• MK-5108 (VX-689): From AURKA Biology to Assays

  2026-09-01

  MK-5108, also known as VX-689, is a highly selective Aurora A kinase inhibitor for cancer research. This article connects its biochemical selectivity with retinoblastoma evidence and shows how to design more informative cell and xenograft studies without overstating translational conclusions.

8122 records 3/542 page Previous Next 12345 下5页 Last page